04-01-2021, 04:11 PM
and now, a little good news
Pfizer’s COVID vaccine effective for at least six months, protects against variants, study says
https://www.nydailynews.com/coronavirus/...story.html
The COVID-19 vaccine developed by Pfizer and its German partner BioNTech remains 91% effective at protecting against coronavirus for at least six months after the second shot.
The findings, released by the drugmakers on Thursday, marks the first look at how long the jabs protect against the virus.
Researchers initially believed the vaccine would only block the virus for about 90 days, but the ongoing Phase 3 clinical trial revealed the time frame is at least double their initial estimates.
According to the newly released findings, there were no major safety concerns among the 12,000 volunteers who are at least six months past their second dose of the vaccine. Researchers noted most participants did experience typical, short-term side effects including fatigue and sore arms.
Out of the 927 trial participants who did become infected with COVID-19 more than a week after their second dose, only 77 received the active vaccine, compared with 850 who got a placebo.
Pfizer’s COVID vaccine effective for at least six months, protects against variants, study says
https://www.nydailynews.com/coronavirus/...story.html
The COVID-19 vaccine developed by Pfizer and its German partner BioNTech remains 91% effective at protecting against coronavirus for at least six months after the second shot.
The findings, released by the drugmakers on Thursday, marks the first look at how long the jabs protect against the virus.
Researchers initially believed the vaccine would only block the virus for about 90 days, but the ongoing Phase 3 clinical trial revealed the time frame is at least double their initial estimates.
According to the newly released findings, there were no major safety concerns among the 12,000 volunteers who are at least six months past their second dose of the vaccine. Researchers noted most participants did experience typical, short-term side effects including fatigue and sore arms.
Out of the 927 trial participants who did become infected with COVID-19 more than a week after their second dose, only 77 received the active vaccine, compared with 850 who got a placebo.